In Person

Antitrust West Coast Conference 2023

May 10 – 11, 2023
San Francisco Marriott Marquis
Event details
May 10 – 11, 2023
San Francisco Marriott Marquis
780 Mission St.
San Francisco, CA

Event summary

Cooley is a proud sponsor of the Antitrust West Coast Conference 2023, presented by Informa Connect. The Antitrust West Coast Conference is the West Coast platform for in-house counsel dealing with global antitrust challenges. 

Featured agenda items

Thursday, May 11, 2023 | 11:40 am – 12:20 pm PDT

Big Data & Competition: Implications for Platforms

Cooley partner Kathleen O’Neill spoke on this panel.

Topics of discussion included:

  • With Big Data and innovation now at the core of every company, what are key antitrust issues on the rise?
  • Competition concerns for sharing/pooling data
  • The way forward for portability and interoperability?
  • Big Data and market power – how deep is the correlation?
  • The economics of Big Data and market power
  • The challenges of data access and competition in 2023
  • Implications for platforms and abuse of dominance
  • Managing a new era of data-centric investigations

Thursday, May 11, 2023 | 2:40 – 3:20 pm PDT

Hunting Healthcare – Increased Scrutiny on Health Systems and Big Pharma

Cooley partner Ethan Glass spoke on this panel.

Topics of discussion included:

  • Reviewing Department of Justice and Federal Trade Commission activity in the space and what to expect in 2023 – 2024
  • Updates on criminal prosecution/is there greater deal uncertainty?
  • How did the November midterm elections affect 2022’s momentum for more scrutiny in the pharmaceutical sector?
  • Developments in healthcare and hospital mergers
  • Mergers and pharmacy benefit management (PBM) companies – what impact is the integration of the largest PBMs with insurers having?
  • The importance of data in healthcare
  • Reviewing recent pharmaceutical and life sciences merger remedies
  • Assessing enforcement against large health systems
  • The FTC’s announcement of a pharmaceutical merger task force and study into the PBM industry
  • European developments in the pharma/healthcare space

For more information, please email Yena Lee.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.